SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

IND-SWIFT LABORATORIES

BSE: 532305 30 Sep 2025
Healthcare
₹ 107.38
Ind-Swift Laboratories Ltd. specializes in Pharmaceuticals within the Healthcare sector.

IND-SWIFT LABORATORIES - Share Price & Details

Market Cap
₹734.0
High /Low
134.0 / 67.2
Stock P/E
33.3
Book Value
₹194.0
Dividend Yield
0.0
ROCE
3.47
ROE
₹3.5
Face Value
10.0
PEG Ratio
0.16
EVEBITDA
₹14.1
Debt
40.8
CMP / FCF
-29.8
Debt to equity
₹0.03
NP Ann
250
High price all time
242.0
Piotroski score
₹3.0
Graham Number
403.0
No. Eq. Shares
7.35
Net CF
₹-65.9
Net profit
226
Price to book value
0.52
Interest Coverage
₹0.3
Low price all time
15.0
Industry PE
33.0
Reserves
₹1,104
Free Cash Flow
₹-51.3

Broker Recommendations

No broker recommendations available

We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.


Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
IND-SWIFT LABORATORIES LTD.1673.1687.751527.341.17734.033.3
Shree Ganesh Remedies LimitedNANANANA66830.6
Prevest Denpro LimitedNANANANA66034.9

Peer Comparison Chart


About IND-SWIFT LABORATORIES

Ind-Swift Laboratories Ltd., with Security Code 532305, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

Ind-Swift Laboratories Announces 30th AGM and Annual Report Availability

(11 Sep 2025)
An update from Ind-Swift Laboratories Ltd. ( ($IN:INDSWFTLAB) ) is now available. Ind-Swift Laboratories Ltd. has announced the scheduling of its 3...
Read more →

Ind-Swift Laboratories Announces Major Share Allotment Amid Amalgamation

(26 Aug 2025)
Ind-Swift Laboratories Ltd. ( ($IN:INDSWFTLAB) ) just unveiled an update. Ind-Swift Laboratories Ltd. has announced the allotment of over...
Read more →

Ind-Swift Laboratories consolidated net profit rises 832.98% in the June 2025 quarter

(18 Aug 2025)
Net profit of Ind-Swift Laboratories rose 832.98% to Rs 8.77 crore in the quarter ended June 2025 as against Rs 0.94 crore during the...
Read more →

Ind-Swift Labs Converts ₹47 Cr Warrants into Equity Shares

(16 Aug 2025)
The warrant conversion and equity allotment by Ind-Swift Labs signals strong promoter and institutional confidence, with a Rs. 47.06 crore...
Read more →

Ind-Swift Laboratories Announces Financial Results and Share Allotment Post-Merger

(12 Aug 2025)
An update from Ind-Swift Laboratories Ltd. ( ($IN:INDSWFTLAB) ) is now available. Ind-Swift Laboratories Ltd. announced the approval of its...
Read more →

Ind-Swift Laboratories Experiences Shift in Technical Indicators Amid Financial Challenges

(28 Jul 2025)
Ind-Swift Laboratories has recently experienced a notable adjustment in its technical indicators, shifting market sentiment. While some metrics show a...
Read more →